Zahra Keshavarz-Motamed

Zahra Keshavarz-Motamed

Auto-generated profile, based on publicly available information

Zahra Keshavarz-Motamed

Department of Mechanical Engineering, McMaster University, Hamilton, Canada

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2022 in IEEE Reviews in Biomedical Engineering
Verified
Journal Article
Closed access
Mason KademMason Kadem
Mason Kadem
LGLouis Garber
Louis Garber
MAMohamed Abdelkhalek
Mohamed Abdelkhalek
BABaraa K. Al-Khazraji
Baraa K. Al-Khazraji
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed
Cardiovascular disease is a deadly global health crisis that carries a substantial financial burden. Innovative treatment and management of cardiovascular disease straddles medicine, personalized hemodynamic modeling, machine learning, and modern imaging to help improve patient outcomes and reduce the economic impact. Hemodynamic modeling offers a non-invasive method to provide clinicians with new pre- and post- procedural metrics and aid in the selection of treatment options. Medical imaging is an integral part in clinical workflows for understanding and managing cardiac disease and interventions. Coupling machine learning with modeling, and cardiovascular imaging, provides faster modeling, improved data fidelity, and an enhanced understanding and earlier detection of cardiovascular anomalies, leading to the development of patient-specific diagnostic and predictive tools for characterizing and assessing cardiovascular outcomes. Herein, we provide a scoping review of translational hemodynamic modeling, medical imaging, and machine learning and their applications to cardiovascular interventions. We particularly focus on providing an intuitive understanding of each of these approaches and their ability to support decision making during important clinical milestones.

1 November 2022 in Energy Reports
Verified
Journal Article
Open access
YWYue Wang
Yue Wang
Atriya BiswasAtriya Biswas
Atriya Biswas
RRRomina Rodriguez
Romina Rodriguez
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed
AEAli Emadi
Ali Emadi

2 December 2021 in Archives of Computational Methods in Engineering
Verified
Journal Article
Closed access
PDF file
LGLouis Garber
Louis Garber
SKSeyedvahid Khodaei
Seyedvahid Khodaei
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed

23 April 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed
Hemodynamics quantification is critically useful for accurate and early diagnosis, but we still lack proper diagnostic methods for many cardiovascular diseases. Furthermore, as most interventions intend to recover the healthy condition, the ability to monitor and predict hemodynamics following interventions can have significant impacts on saving lives. Predictive methods are rare, enabling prediction of effects of interventions, allowing timely and personalized interventions and helping critical clinical decision making about life-threatening risks based on quantitative data. In this study, an innovative non-invasive imaged-based patient-specific diagnostic, monitoring and predictive tool (called C3VI-CMF) was developed, enabling quantifying (1) details of physiological flow and pressures through the heart and circulatory system; (2) heart function metrics. C3VI-CMF also predicts the breakdown of the effects of each disease constituents on the heart function. Presently, neither of these can be obtained noninvasively in patients and when invasive procedures are undertaken, the collected metrics cannot be by any means as complete as the ones C3VI-CMF provides. C3VI-CMF purposefully uses a limited number of noninvasive input parameters all of which can be measured using Doppler echocardiography and sphygmomanometer. Validation of C3VI-CMF, against cardiac catheterization in forty-nine patients with complex cardiovascular diseases, showed very good agreement with the measurements.

25 May 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SKSeyedvahid Khodaei
Seyedvahid Khodaei
AHAlison Henstock
Alison Henstock
RSReza Sadeghi
Reza Sadeghi
SSStephanie Sellers
Stephanie Sellers
PBPhilipp Blanke
Philipp Blanke
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed
One of the most common acute and chronic cardiovascular disease conditions is aortic stenosis, a disease in which the aortic valve is damaged and can no longer function properly. Moreover, aortic stenosis commonly exists in combination with other conditions causing so many patients suffer from the most general and fundamentally challenging condition: complex valvular, ventricular and vascular disease (C3VD). Transcatheter aortic valve replacement (TAVR) is a new less invasive intervention and is a growing alternative for patients with aortic stenosis. Although blood flow quantification is critical for accurate and early diagnosis of C3VD in both pre and post-TAVR, proper diagnostic methods are still lacking because the fluid-dynamics methods that can be used as engines of new diagnostic tools are not well developed yet. Despite remarkable advances in medical imaging, imaging on its own is not enough to quantify the blood flow effectively. Moreover, understanding of C3VD in both pre and post-TAVR and its progression has been hindered by the absence of a proper non-invasive tool for the assessment of the cardiovascular function. To enable the development of new non-invasive diagnostic methods, we developed an innovative image-based patient-specific computational fluid dynamics framework for patients with C3VD who undergo TAVR to quantify metrics of: (1) global circulatory function; (2) global cardiac function as well as (3) local cardiac fluid dynamics. This framework is based on an innovative non-invasive Doppler-based patient-specific lumped-parameter algorithm and a 3-D strongly-coupled fluid-solid interaction. We validated the framework against clinical cardiac catheterization and Doppler echocardiographic measurements and demonstrated its diagnostic utility by providing novel analyses and interpretations of clinical data in eleven C3VD patients in pre and post-TAVR status. Our findings position this framework as a promising new non-invasive diagnostic tool that can provide blood flow metrics while posing no risk to the patient. The diagnostic information, that the framework can provide, is vitally needed to improve clinical outcomes, to assess patient risk and to plan treatment.

1 September 2016 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
ZKZahra Keshavarz-Motamed
Zahra Keshavarz-Motamed
FNFarhad Rikhtegar Nezami
Farhad Rikhtegar Nezami
RPRamon A. Partida
Ramon A. Partida
KNKenta Nakamura
Kenta Nakamura
PSPedro Vinícius Staziaki
Pedro Vinícius Staziaki
Elazer R. EdelmanElazer R. Edelman
Elazer R. Edelman